While immune exclusion is generally associated with resistance to therapies like immune checkpoint inhibitors [63], stromal CD8+ T cells may still indicate an active immune response that limits tumor progression through interactions with other immune cells, such as macrophages and dendritic cells [64]. Here, CD8A is linked to neoplasm.